Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001618131 | SCV001847253 | benign | not provided | 2021-02-15 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function |
Labcorp Genetics |
RCV002539568 | SCV003272222 | benign | Rubinstein-Taybi syndrome | 2023-01-02 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV001618131 | SCV004235509 | uncertain significance | not provided | 2023-11-01 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003980813 | SCV004786348 | likely benign | CREBBP-related disorder | 2022-04-11 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |